MX5770E - Procedimiento para la sintesis quimica de derivados del fragmento 63-91 de la beta-lipotropina de mamifero - Google Patents

Procedimiento para la sintesis quimica de derivados del fragmento 63-91 de la beta-lipotropina de mamifero

Info

Publication number
MX5770E
MX5770E MX787146U MX714678U MX5770E MX 5770 E MX5770 E MX 5770E MX 787146 U MX787146 U MX 787146U MX 714678 U MX714678 U MX 714678U MX 5770 E MX5770 E MX 5770E
Authority
MX
Mexico
Prior art keywords
lipotropin
mammalian
fragment
beta
derivatives
Prior art date
Application number
MX787146U
Other languages
English (en)
Spanish (es)
Inventor
David Howard Coy
Abba Jeremiah Kastin
Original Assignee
David Howard Coy
Abba Jeremiah Kastin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by David Howard Coy, Abba Jeremiah Kastin filed Critical David Howard Coy
Publication of MX5770E publication Critical patent/MX5770E/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/675—Beta-endorphins
    • C07K14/6755—Beta-endorphins with at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MX787146U 1977-06-16 1978-06-14 Procedimiento para la sintesis quimica de derivados del fragmento 63-91 de la beta-lipotropina de mamifero MX5770E (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80712777A 1977-06-16 1977-06-16

Publications (1)

Publication Number Publication Date
MX5770E true MX5770E (es) 1984-07-06

Family

ID=25195641

Family Applications (1)

Application Number Title Priority Date Filing Date
MX787146U MX5770E (es) 1977-06-16 1978-06-14 Procedimiento para la sintesis quimica de derivados del fragmento 63-91 de la beta-lipotropina de mamifero

Country Status (11)

Country Link
JP (1) JPS5470216A (fr)
AU (1) AU3710778A (fr)
BE (1) BE868218A (fr)
DE (1) DE2826533A1 (fr)
FR (1) FR2394521A1 (fr)
GB (1) GB2000151B (fr)
IL (1) IL54920A0 (fr)
IT (1) IT1099555B (fr)
MX (1) MX5770E (fr)
NL (1) NL7806540A (fr)
ZA (1) ZA783287B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2960258D1 (en) * 1978-03-02 1981-05-07 Akzo Nv Psychopharmacological peptides, process for their preparation and their pharmaceutical formulations
US4330465A (en) * 1978-03-02 1982-05-18 Hoffmann-La Roche Inc. Novel β-endorphin analogs
AU530062B2 (en) * 1979-02-21 1983-06-30 Akzo N.V. Psycho-pharmacological peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038222A (en) * 1976-03-17 1977-07-26 Hoffman-La Roche Inc. Untriakontapeptide with opiate activity

Also Published As

Publication number Publication date
GB2000151B (en) 1982-03-17
IT1099555B (it) 1985-09-18
GB2000151A (en) 1979-01-04
NL7806540A (nl) 1978-12-19
BE868218A (fr) 1978-10-16
AU3710778A (en) 1979-12-20
DE2826533A1 (de) 1979-01-11
JPS5470216A (en) 1979-06-05
IT7824664A0 (it) 1978-06-16
ZA783287B (en) 1980-01-30
FR2394521A1 (fr) 1979-01-12
IL54920A0 (en) 1978-08-31

Similar Documents

Publication Publication Date Title
MX4811E (es) Procedimiento para preparar derivados de prostaglandina
MX4988E (es) Procedimiento para la preparacion de derivados pirrolidinicos
MX148042A (es) Procedimiento mejorado para la produccion de urea-amoniaco
MX4614E (es) Procedimiento mejorado para la preparacion de derivados de pirimidina
MX5119E (es) Procedimiento mejorado para la preparacion de derivados de pirimidona
AR221081A1 (es) Procedimiento para preparar derivados de fenoximetil-piperidino-propoxi-indol
BR7601473A (pt) Placa-escala para instrumentos de medicao
ES493107A0 (es) Procedimiento de preparacion de nuevos derivados del a-fe- nil-2-pirrolidin-metanol
BE843381A (fr) Procede de preparation de thymol
AR208001A1 (es) Procedimiento mejorado para la produccion de uroquinasa
AR222844A1 (es) Procedimiento para la obtencion de nuevos derivados de n1-glucofuranosil-6-ilo-n3-nitroso-ureas
MX5770E (es) Procedimiento para la sintesis quimica de derivados del fragmento 63-91 de la beta-lipotropina de mamifero
AR223465A1 (es) Procedimiento para obtener derivados de 5-bencil-2,4-diamino-pirimidinas
MX4884E (es) Procedimiento para la preparacion de derivados de la tienopiridina
ES499914A0 (es) Procedimiento para la obtencion de derivados del amino-tia- diazolilo
AR215142A1 (es) Procedimiento de obtencion de derivados del(3-amino monosubstituido-2-hidroxipropoxi)-tiocromano
PT68821A (fr) Procede de preparation de derives de naphtalene
BE871068A (fr) Nouveau procede de preparation de 4-chloroquinoleines
RO68209A (fr) Procede pour la preparation des arylalkylaminoalkylphtalimidines
BE840151A (fr) Procede de preparation de 3-methyl-piperidine
MX4836E (es) Procedimiento para la preparacion de derivados de aminoetanol
AR220130A1 (es) Procedimiento para la sintesis de s-triacinas fluoradas
MX4457E (es) Procedimiento mejorado para la preparacion de derivados substituidos de 2h-piran-2,6(3h)-diona
AR214305A1 (es) Procedimiento para la produccion de n-acetiltienamicina
AR214394A1 (es) Procedimiento para obtener derivados cuaternarios de xantini lalquilnortropina